Side Effects Acknowledged By AstraZeneca's For Covishield Vaccine

  • AstraZeneca has acknowledged the potential for rare but serious side effects associated with their COVID-19 vaccine, Covishield.
  • This follows reports of Thrombosis with Thrombocytopenia Syndrome (TTS) in a small number of individuals who received the vaccine.
  • TTS is a condition characterized by blood clots and low blood platelet count.
  • AstraZeneca emphasizes the extreme rarity of these side effects, reiterating the overall safety and efficacy of the Covishield vaccine.
  • The company advises healthcare professionals and individuals to be aware of the signs and symptoms of TTS for prompt medical attention if needed.

Comments

Popular posts from this blog

Sky High Surge: IndiGo Soars as India’s Air Passenger Traffic Climbs 8.4% in April

IndiGo Set to Make History: First to Soar from Navi Mumbai Airport with 18 Daily Flights!

RBI’s Record Dividend Bonanza: Government’s Coffers Swell by Rs 2.69 Lakh Crore for FY 2024-25